GlassScriptPhysician profile
Leo Ungar
NPI 1851702088
$20,985.38
in general payments reported to CMS, 2019-2025
33 companies · $3,981 in 2025
The $3,981 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,326 · 2020: $169 · 2021: $206 · 2022: $2,279 · 2023: $5,837 · 2024: $5,187 · 2025: $3,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,930 · Travel and Lodging: $5,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,929.65 |
| Travel and Lodging | $5,075.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,029.55 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $4,002.43 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,705.91 | 2020-2025 | Emblem Mri S-Icd, Watchman Flx, General - Tachy |
| Pfizer INC. | $782.28 | 2019-2025 | |
| Cardiva Medical, INC. | $726.48 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novartis Pharmaceuticals Corporation | $688.76 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $365.12 | 2024-2025 | Verquvo, Capvaxive |
| Kestra Medical Technology Services, INC. | $246.76 | 2024-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $234.86 | 2022-2025 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.91 | 2022-2025 | Jardiance |
| Cordis US Corp. | $208.90 | 2025 | Mynx Control Venous, Mynx Control |
| Lexicon Pharmaceuticals, INC. | $194.70 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $161.08 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $155.25 | 2023-2024 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $146.31 | 2022-2025 | Wainua, Farxiga |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $132.48 | 2024-2025 | Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.94 | 2023-2025 | Lifevest |
| Atricure, INC. | $108.25 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $89.67 | 2022-2023 | Arcalyst |
| Lilly USA, LLC | $84.64 | 2023-2024 | Mounjaro |
| Amgen INC. | $79.40 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $76.80 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $63.60 | 2019-2024 | Camzyos |
| Baylis Medical Company INC | $56.39 | 2021 | |
| Inspire Medical Systems, INC. | $41.62 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $40.58 | 2023 | Nexletol |
| Philips North America LLC | $37.04 | 2023-2024 | (5044) Mcot |
| Janssen Pharmaceuticals, INC | $36.74 | 2023-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $33.38 | 2024-2025 | Gore Cardioform Septal Occluder |
| Ethicon US, LLC | $28.96 | 2025 | Stratafix, Dermabond |
| Liquidia Technologies, INC. | $28.19 | 2025 | Yutrepia |
| Cardiovascular Systems INC. | $17.96 | 2019 | |
| Altathera Pharmaceuticals LLC | $16.44 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Ungar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.